Therafirst Medical Center
Fort Lauderdale, Florida, United States
Medical center in Oakland Park, Florida
4011 N Federal Hwy, Fort Lauderdale, FL 33308
About Therafirst Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
20
Pharmacia
3
Boehringer Ingelheim
2
Chembio Diagnostic Systems, Inc.
2
Glaxo Wellcome
2
Repros Therapeutics Inc.
2
Samaritan Pharmaceuticals, Inc
2
Abbott
1
Agouron Pharmaceuticals
1
Amgen
1
Bristol-Myers Squibb
1
Clinical Trials at Therafirst Medical Center
During the past decade, Therafirst Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on
average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
Completed
200
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Completed
750
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
Completed
450
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Completed
250
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
1994-12-01
Completed
SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
Completed
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
1992-11-01
1994-11-01
Completed
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
Completed
30
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Therafirst Medical Center" #1 sponsor was "Gilead Sciences" with 20 trials, followed by "Pharmacia" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Chembio Diagnostic Systems, Inc." with 2 trials sponsored and "Glaxo Wellcome"
with 2 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Therafirst Medical Center"
#1 collaborator was "Alquest" with 1 trials as a collaborator and "SMART Biotech Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Therafirst Medical Center
According to Clinical.Site data, the most researched conditions in "Therafirst Medical Center" are
"HIV Infections" (29 trials), "HIV-1 Infection" (7 trials), "HIV" (4 trials), "Acquired Immunodeficiency Syndrome" (2 trials) and "HIV Infection" (2 trials). Many other conditions were trialed in "Therafirst Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Therafirst Medical Center
Most popular intervention types in "Therafirst Medical Center" are "Drug" (42 trials), "Device" (2 trials), "Diagnostic Test" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "ATV" (4 trials), "FTC/TDF" (4 trials), "B/F/TAF" (3 trials), "COBI" (3 trials) and "E/C/F/TAF" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Therafirst Medical Center
The vast majority of trials in "Therafirst Medical Center" are
46 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Therafirst Medical Center
Currently, there are NaN active trials in "Therafirst Medical Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 41 completed trials in Therafirst Medical Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Therafirst Medical Center, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 10 trials that are defined as “Not Applicable".